PL142759B1 - Process for preparing derivatives of hydantoin - Google Patents

Process for preparing derivatives of hydantoin Download PDF

Info

Publication number
PL142759B1
PL142759B1 PL1984247379A PL24737984A PL142759B1 PL 142759 B1 PL142759 B1 PL 142759B1 PL 1984247379 A PL1984247379 A PL 1984247379A PL 24737984 A PL24737984 A PL 24737984A PL 142759 B1 PL142759 B1 PL 142759B1
Authority
PL
Poland
Prior art keywords
fluoro
spiro
compounds
dione
product
Prior art date
Application number
PL1984247379A
Other languages
English (en)
Polish (pl)
Other versions
PL247379A1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL247379A1 publication Critical patent/PL247379A1/xx
Publication of PL142759B1 publication Critical patent/PL142759B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL1984247379A 1983-04-27 1984-04-24 Process for preparing derivatives of hydantoin PL142759B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/488,947 US4474967A (en) 1983-04-27 1983-04-27 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione

Publications (2)

Publication Number Publication Date
PL247379A1 PL247379A1 (en) 1985-03-26
PL142759B1 true PL142759B1 (en) 1987-11-30

Family

ID=23941785

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1984247379A PL142759B1 (en) 1983-04-27 1984-04-24 Process for preparing derivatives of hydantoin

Country Status (22)

Country Link
US (1) US4474967A (enEXAMPLES)
EP (1) EP0124327A3 (enEXAMPLES)
JP (1) JPS59205384A (enEXAMPLES)
KR (1) KR860000915B1 (enEXAMPLES)
AU (1) AU542142B2 (enEXAMPLES)
CA (1) CA1226866A (enEXAMPLES)
CS (1) CS250661B2 (enEXAMPLES)
DD (1) DD219772A5 (enEXAMPLES)
DK (1) DK208284A (enEXAMPLES)
ES (1) ES8607312A1 (enEXAMPLES)
FI (1) FI841657A7 (enEXAMPLES)
GR (1) GR81491B (enEXAMPLES)
HU (1) HU191755B (enEXAMPLES)
IL (1) IL71656A (enEXAMPLES)
NO (1) NO841627L (enEXAMPLES)
NZ (1) NZ207959A (enEXAMPLES)
PH (1) PH22869A (enEXAMPLES)
PL (1) PL142759B1 (enEXAMPLES)
PT (1) PT78476B (enEXAMPLES)
SU (1) SU1240362A3 (enEXAMPLES)
YU (1) YU43358B (enEXAMPLES)
ZA (1) ZA843091B (enEXAMPLES)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3565105D1 (en) * 1984-08-20 1988-10-27 Pfizer Process for the production as asymmetric hydantoins
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
GB9317764D0 (en) * 1993-08-26 1993-10-13 Pfizer Ltd Therapeutic compound
EP1004307B1 (en) * 1998-01-30 2002-09-04 R-Tech Ueno, Ltd. Ophthalmic composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation

Also Published As

Publication number Publication date
HU191755B (en) 1987-04-28
EP0124327A2 (en) 1984-11-07
US4474967A (en) 1984-10-02
KR860000915B1 (ko) 1986-07-18
ES8607312A1 (es) 1986-06-01
SU1240362A3 (ru) 1986-06-23
PH22869A (en) 1989-01-19
NZ207959A (en) 1987-04-30
NO841627L (no) 1984-10-29
IL71656A0 (en) 1984-07-31
GR81491B (enEXAMPLES) 1984-12-11
DD219772A5 (de) 1985-03-13
AU2726384A (en) 1984-11-01
DK208284D0 (da) 1984-04-26
AU542142B2 (en) 1985-02-07
YU43358B (en) 1989-06-30
HUT34197A (en) 1985-02-28
FI841657A0 (fi) 1984-04-26
DK208284A (da) 1984-10-28
FI841657L (fi) 1984-10-28
CS250661B2 (en) 1987-05-14
ZA843091B (en) 1985-12-24
FI841657A7 (fi) 1984-10-28
YU74184A (en) 1986-10-31
IL71656A (en) 1987-10-20
PT78476A (en) 1984-05-01
EP0124327A3 (en) 1985-07-31
PL247379A1 (en) 1985-03-26
JPS59205384A (ja) 1984-11-20
CA1226866A (en) 1987-09-15
ES531873A0 (es) 1986-06-01
KR840008355A (ko) 1984-12-14
PT78476B (en) 1986-08-28

Similar Documents

Publication Publication Date Title
De Sarro et al. 5H-[1, 2, 4] Oxadiazolo [5, 4-d][1, 5] benzothiazepines as anticonvulsant agents in DBA/2 mice
Tan et al. Synthesis, DNA binding and cytotoxicity of new pyrazole emodin derivatives
CA1284322C (en) 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4- dihydro-5h-2,3-benzodiazepine and a process for preparing same
Hoffman et al. Synthesis and LSD-like discriminative stimulus properties in a series of N (6)-alkyl norlysergic acid N, N-diethylamide derivatives
AU2016302755A1 (en) 5-HT2C receptor agonists and compositions and methods of use
US5476933A (en) Azepine synthesis via a diels-alder reaction
SK165795A3 (en) 3-phenylizoquinoline-1(2h)-one derivatives, preparation method and pharmaceutical compounds containing these derivatives
US4490381A (en) 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones
EP1726304A1 (en) Solifenacin-containing composition
Gallos et al. Expeditious synthesis of aminocyclopentitols from D-ribose via intramolecular nitrone cycloaddition
Hajlaoui et al. Design, Synthesis and biological evaluation of novel benzopyran derivatives as potential α-amylase inhibitors: An Investigation by Experimental and Computational Studies
PL142759B1 (en) Process for preparing derivatives of hydantoin
US6030979A (en) Pharmaceutical composition comprising 5,6-dihydrodibenzo[A,G] Quinolizinium derivatives and the salts thereof
AU597687B2 (en) Dibenz(b,e)oxepin derivative and pharmaceutical containing the same as active ingredient
EP3844152B1 (en) Substituted heterocycles as c-myc targeting agents
AU701412B2 (en) Fused isoindolones
CN116655638B (zh) 氘代prmt5抑制剂
EP4610256A1 (en) Piperidinopyrimidine derivative, preparation method therefor and use thereof in medicine
Bertha et al. (E)-8-Benzylidene Derivatives of 2-Methyl-5-(3-hydroxyphenyl) morphans: Highly Selective Ligands for the. sigma. 2 Receptor Subtype
Watthey et al. Synthesis and biological properties of thiophene ring analogs of mianserin
EP2367785B1 (en) Novel 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
Robbins et al. (Aminoalkyl) carbamates of forskolin: intermediates for the synthesis of functionalized derivatives of forskolin with different specificities for adenylyl cyclase and the glucose transporter
CN117999264A (zh) 三环化合物及其制备方法
AU615907B2 (en) Benzofuro (3,2-c) quinoline compounds
De Costa et al. Novel site-directed affinity ligands for GABA-gated chloride channels: Synthesis, characterization, and molecular modeling of 1-(Isothiocyanatophenyl)-4-tert-butyl-2, 6, 7-trioxabicyclo [2.2. 2] octanes